Access 2.8M+ Filings Sign Up Free
Ovoca Bio Plc Logo

Ovoca Bio Plc | OVXA - Profile, Filings, Stock Info & Investor Relations Data

Ovoca Bio Plc | OVXA
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Ireland
Founded
1985
Ovoca Bio Plc (OVXA)

Company Profile

Website
Investor Relations

About Ovoca Bio Plc

Ovoca Bio is a clinical-stage biopharmaceutical company focused on women’s health. In 2018 the Company acquired control of IVIX, a biotechnology company developing Orenetide (BP-101), a novel medicinal treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). Since the initial acquisition, Ovoca Bio has supported the continued clinical development and commercial planning of Orenetide, which has been submitted for marketing authorisation in Russia and has commenced a Phase II study in a western population with HSDD. In March 2020, Orenetide became a fully owned program of Ovoca Bio.

Founded and incorporated in Ireland, the business currently operates in Ireland, the UK and Russia.

Market Presence

Irland, UK, Russia

Headquarters

17 PEMBROKE STREET UPPER
D02 AT22, DUBLIN
Ireland

Ovoca Bio Plc (OVXA)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Ovoca Bio Plc (OVXA)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Ovoca Bio Plc (OVXA)
Stock & Investor Information

ISINs

IE0006649010
IE00B4XVDC01

LEI

213800ST2AK5XQ1O5207

Stock Exchange Listings

Euronext Dublin

Stock Index Memberships

ISEQ Overall Index

Industry Classification

Sector
Health Care
Industry
Biotechnology